• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤细胞上的EphB4与血管内皮素B2之间的相互作用调节肿瘤生长。

Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.

作者信息

Noren Nicole K, Lu Mark, Freeman Andrew L, Koolpe Mitchell, Pasquale Elena B

机构信息

The Burnham Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.

出版信息

Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5583-8. doi: 10.1073/pnas.0401381101. Epub 2004 Apr 5.

DOI:10.1073/pnas.0401381101
PMID:15067119
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC397426/
Abstract

Receptor tyrosine kinases of the Eph family are up-regulated in different types of cancer. EphB4 and its ligand ephrin-B2 have been linked to breast cancer, but little is known about how this receptor-ligand complex may contribute to oncogenesis. The Eph receptors transmit forward signals via their kinase domain and reverse signals via their transmembrane ephrin-B ligands. Therefore, we used EphB4 that were lacking the kinase domain and tagged with EGFP (EphB4 Delta C-EGFP) to differentiate between EphB4 and ephrin-B2 signaling. Interestingly, we found that expression of EphB4 Delta C-EGFP in breast cancer cells increases tumor growth in a mouse xenograft model. Given the undetectable EphB4 activation in the tumor cells, dominant negative effects of EphB4 Delta C-EGFP are unlikely to explain the increased tumor growth. Examination of the tumors revealed that ephrin-B2 is primarily expressed in the vasculature and that the EphB4 Delta C-EGFP tumors have a higher blood content than control tumors, concomitant with increased size of blood vessels. In support of an effect on the vasculature, the extracellular domain of EphB4 attracts endothelial cells in vitro and stimulates endothelial cell invasion, survival, and proliferation, all crucial factors for angiogenesis. These results support a model in which EphB4 promotes tumor growth by stimulating angiogenesis through ephrin-B2.

摘要

Eph家族的受体酪氨酸激酶在不同类型的癌症中上调。EphB4及其配体ephrin - B2与乳腺癌有关,但对于这种受体 - 配体复合物如何促进肿瘤发生知之甚少。Eph受体通过其激酶结构域传递正向信号,并通过其跨膜ephrin - B配体传递反向信号。因此,我们使用缺乏激酶结构域并标记有EGFP的EphB4(EphB4 Delta C - EGFP)来区分EphB4和ephrin - B2信号。有趣的是,我们发现在小鼠异种移植模型中,乳腺癌细胞中EphB4 Delta C - EGFP的表达增加了肿瘤生长。鉴于肿瘤细胞中未检测到EphB4激活,EphB4 Delta C - EGFP的显性负效应不太可能解释肿瘤生长的增加。对肿瘤的检查显示,ephrin - B2主要在脉管系统中表达,并且EphB4 Delta C - EGFP肿瘤的血液含量高于对照肿瘤,同时血管大小增加。为支持对脉管系统的影响,EphB4的细胞外结构域在体外吸引内皮细胞并刺激内皮细胞侵袭、存活和增殖,这些都是血管生成的关键因素。这些结果支持了一个模型,即EphB4通过ephrin - B2刺激血管生成来促进肿瘤生长。

相似文献

1
Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.肿瘤细胞上的EphB4与血管内皮素B2之间的相互作用调节肿瘤生长。
Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5583-8. doi: 10.1073/pnas.0401381101. Epub 2004 Apr 5.
2
Distinct roles of ephrin-B2 forward and EphB4 reverse signaling in endothelial cells.内皮细胞中ephrin-B2正向信号和EphB4反向信号的不同作用。
Arterioscler Thromb Vasc Biol. 2003 Feb 1;23(2):190-7. doi: 10.1161/01.atv.0000055440.89758.c2.
3
Evidence for a dual function of EphB4 as tumor promoter and suppressor regulated by the absence or presence of the ephrin-B2 ligand.EphB4 作为肿瘤促进因子和抑制因子的双重功能的证据,受 Ephrin-B2 配体的有无调控。
Int J Cancer. 2012 Sep 1;131(5):E614-24. doi: 10.1002/ijc.27392. Epub 2012 Jan 11.
4
Ephrin-B2 reverse signaling is required for axon pathfinding and cardiac valve formation but not early vascular development.Ephrin-B2反向信号传导对于轴突寻路和心脏瓣膜形成是必需的,但对于早期血管发育并非必需。
Dev Biol. 2004 Jul 15;271(2):263-71. doi: 10.1016/j.ydbio.2004.03.026.
5
Ephrin B2 and EphB4 selectively mark arterial and venous vessels in cerebral arteriovenous malformation.Ephrin B2和EphB4可选择性标记脑动静脉畸形中的动脉和静脉血管。
J Int Med Res. 2014 Apr;42(2):405-15. doi: 10.1177/0300060513478091. Epub 2014 Feb 11.
6
The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway.EphB4受体通过Abl-Crk信号通路抑制乳腺癌细胞的致瘤性。
Nat Cell Biol. 2006 Aug;8(8):815-25. doi: 10.1038/ncb1438. Epub 2006 Jul 23.
7
Regulation of signaling interactions and receptor endocytosis in growing blood vessels.生长血管中信号转导相互作用和受体内化的调节。
Cell Adh Migr. 2014;8(4):366-77. doi: 10.4161/19336918.2014.970010.
8
Ligand-Dependent and Ligand-Independent Effects of Ephrin-B2-EphB4 Signaling in Melanoma Metastatic Spine Disease.Ephrin-B2-EphB4 信号在黑色素瘤转移脊柱疾病中的配体依赖性和配体非依赖性作用。
Int J Mol Sci. 2021 Jul 27;22(15):8028. doi: 10.3390/ijms22158028.
9
The role of Ephs, Ephrins, and growth factors in Kaposi sarcoma and implications of EphrinB2 blockade.Eph受体、Ephrin配体和生长因子在卡波西肉瘤中的作用及EphrinB2阻断的意义
Blood. 2009 Jan 1;113(1):254-63. doi: 10.1182/blood-2008-02-140020. Epub 2008 Oct 3.
10
Receptor tyrosine kinase EphB4 is a survival factor in breast cancer.受体酪氨酸激酶EphB4是乳腺癌中的一种生存因子。
Am J Pathol. 2006 Jul;169(1):279-93. doi: 10.2353/ajpath.2006.050889.

引用本文的文献

1
Trial in progress: phase I study of non-viral gene-modified CAR-T cell therapy for malignant solid tumors expressing EPHB4 receptor (CARTiEr).试验进行中:针对表达EPHB4受体的恶性实体瘤的非病毒基因修饰CAR-T细胞疗法(CARTiEr)的I期研究
Front Oncol. 2025 Aug 6;15:1633324. doi: 10.3389/fonc.2025.1633324. eCollection 2025.
2
EphB4-ephrin-B2 are targets in castration resistant prostate cancer.EphB4-ephrin-B2是去势抵抗性前列腺癌的靶点。
Br J Cancer. 2025 May;132(8):679-689. doi: 10.1038/s41416-025-02942-5. Epub 2025 Mar 5.
3
Feasibility of Intratumoral Administration With EPHB4-CAR-T Cells for the Treatment of Oral Squamous Cell Carcinoma.EPHB4嵌合抗原受体T细胞瘤内给药治疗口腔鳞状细胞癌的可行性
Cancer Sci. 2025 May;116(5):1227-1238. doi: 10.1111/cas.70023. Epub 2025 Mar 3.
4
Manipulating the EphB4-ephrinB2 axis to reduce metastasis in HNSCC.通过调控EphB4-ephrinB2轴来减少头颈部鳞状细胞癌的转移。
Oncogene. 2025 Feb;44(3):130-146. doi: 10.1038/s41388-024-03208-9. Epub 2024 Nov 3.
5
Manipulating the EphB4-ephrinB2 axis to reduce metastasis in HNSCC.通过调控EphB4-ephrinB2轴来减少头颈部鳞状细胞癌的转移。
bioRxiv. 2024 Jul 23:2024.07.21.604518. doi: 10.1101/2024.07.21.604518.
6
Identification of potent pan-ephrin receptor kinase inhibitors using DNA-encoded chemistry technology.利用DNA编码化学技术鉴定有效的泛肾上腺素受体激酶抑制剂。
Proc Natl Acad Sci U S A. 2024 May 7;121(19):e2322934121. doi: 10.1073/pnas.2322934121. Epub 2024 May 3.
7
Diversity of Intercellular Communication Modes: A Cancer Biology Perspective.细胞间通讯模式的多样性:癌症生物学视角。
Cells. 2024 Mar 12;13(6):495. doi: 10.3390/cells13060495.
8
Inhibition of Ephrin B2 Reverse Signaling Abolishes Multiple Myeloma Pathogenesis.抑制 Ephrin B2 反向信号可消除多发性骨髓瘤的发病机制。
Cancer Res. 2024 Mar 15;84(6):919-934. doi: 10.1158/0008-5472.CAN-23-1950.
9
EphrinB2: Expression of a novel potential target in renal cell carcinoma.EphrinB2:肾细胞癌中一种新型潜在靶点的表达
Indian J Urol. 2023 Jul-Sep;39(3):223-227. doi: 10.4103/iju.iju_92_23. Epub 2023 Jun 30.
10
Anti-angiogenic therapy in ovarian cancer: Current understandings and prospects of precision medicine.卵巢癌的抗血管生成治疗:精准医学的当前认识与前景
Front Pharmacol. 2023 Mar 7;14:1147717. doi: 10.3389/fphar.2023.1147717. eCollection 2023.

本文引用的文献

1
Role of ephrin B2 in human retinal endothelial cell proliferation and migration.Ephrin B2在人视网膜内皮细胞增殖和迁移中的作用。
Cell Signal. 2003 Nov;15(11):1011-7. doi: 10.1016/s0898-6568(03)00072-x.
2
Ephrin B2 induces T cell costimulation.Ephrin B2诱导T细胞共刺激。
J Immunol. 2003 Jul 1;171(1):106-14. doi: 10.4049/jimmunol.171.1.106.
3
'Eph'ective signaling: forward, reverse and crosstalk.“Eph”有效信号传导:正向、反向及串扰。
J Cell Sci. 2003 Jul 15;116(Pt 14):2823-32. doi: 10.1242/jcs.00625.
4
Molecular regulation of vessel maturation.血管成熟的分子调控
Nat Med. 2003 Jun;9(6):685-93. doi: 10.1038/nm0603-685.
5
Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells.内皮细胞中正向EphB4信号传导控制细胞排斥以及与ephrinB2阳性细胞的分离。
J Cell Sci. 2003 Jun 15;116(Pt 12):2461-70. doi: 10.1242/jcs.00426. Epub 2003 May 6.
6
Ephrin-B1 reverse signaling activates JNK through a novel mechanism that is independent of tyrosine phosphorylation.Ephrin-B1反向信号传导通过一种不依赖酪氨酸磷酸化的新机制激活JNK。
J Biol Chem. 2003 Jul 4;278(27):24767-75. doi: 10.1074/jbc.M302454200. Epub 2003 Apr 22.
7
EphB4 receptor tyrosine kinase transgenic mice develop glomerulopathies reminiscent of aglomerular vascular shunts.EphB4受体酪氨酸激酶转基因小鼠会出现类似于无肾小球血管分流的肾小球病变。
Mech Dev. 2003 Apr;120(4):511-6. doi: 10.1016/s0925-4773(02)00461-6.
8
Differential regulation of EphA2 in normal and malignant cells.EphA2在正常细胞和恶性细胞中的差异调节。
Am J Pathol. 2003 Apr;162(4):1037-42. doi: 10.1016/S0002-9440(10)63899-0.
9
Distinct roles of ephrin-B2 forward and EphB4 reverse signaling in endothelial cells.内皮细胞中ephrin-B2正向信号和EphB4反向信号的不同作用。
Arterioscler Thromb Vasc Biol. 2003 Feb 1;23(2):190-7. doi: 10.1161/01.atv.0000055440.89758.c2.
10
Activation of the receptor protein tyrosine kinase EphB4 in endometrial hyperplasia and endometrial carcinoma.受体蛋白酪氨酸激酶EphB4在子宫内膜增生和子宫内膜癌中的激活。
Ann Oncol. 2003 Feb;14(2):220-6. doi: 10.1093/annonc/mdg072.